Real Time Genomics

Certara has released version 13 of the Simcyp Simulator, its software for quantitative prediction of drug-drug-interactions and pharmacokinetic-pharmacodynamic outcomes in virtual populations.

Partners HealthCare has launched clinical whole-genome sequencing and interpretation services for patients with suspected genetic conditions as a collaboration between Partners Laboratory for Molecular Medicine, Mass General Hospital and

NEW YORK (GenomeWeb News) – Real Time Genomics today announced a $5 million investment for the expansion of its commercial operations.

Real Time Genomics and Knome will integrate Real Time Genomics' Variant platform into Knome's KnoSys 1000 interpretation system.

NEW YORK (GenomeWeb News) – Real Time Genomics and Knome today announced a deal to integrate the Real Time Genomics Variant platform into every shipment of the knoSys 100 interpretation system.

NEW YORK (GenomeWeb News) – Real Time Genomics and the J. Craig Venter Institute have forged a long-term research pact focused on analyzing the genetic mutations that induced pluripotent stem cells acquire during differentiation, RTG said today.

NEW YORK (GenomeWeb News) – Real Time Genomics and Omicia today announced a deal to integrate each other's platforms into a workflow for identifying disease-causing variants in whole genomes and exomes for the clinical interpretation of genomes for childhood diseases.

Susan Siegel has resigned from Pacific Biosciences' board of directors and David Singer said that he will not stand for re-election to the board at the company's 2013 annual meeting of stockholders.

This week, the International Society for Computational Biology said that David Eisenberg and Goncalo Abecasis have won the 2013 Senior Scientist award and Overton Prize Award respectively.

Life Technologies has launched new products for its Ion Torrent sequencing systems. The Ion Library Equalizer Kits eliminate the need for library quantification and library dilutions prior to clonal amplification for Ion AmpliSeq experiments.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.